DVT & Pulmonary Embolism
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Conference Coverage
Know the right resuscitation for right-sided heart failure
Research has demonstrated the differences in physiology between the right and left ventricles, expert says.
Conference Coverage
Thromboembolic events more likely among CIDP patients with CVAD
AUSTIN, TEX. – Although the study matched patients by demographic factors, researchers did not adjust the analysis for risk factors or confounders...
Conference Coverage
Rivaroxaban tied to higher GI bleeding than other NOACs
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
From the Journals
ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban
Reductions were similar for those receiving apixaban and rivaroxaban.
Latest News
ATTRACT trial shouldn’t detract from pharmacomechanical thrombolysis
CHICAGO –
Conference Coverage
EHR-guided strategy reduces postop VTE events
BOSTON – Missed doses of enoxaparin correlate with increased incidence of deep vein thrombosis.
Conference Coverage
Idarucizumab reversed dabigatran completely and rapidly in study
One drug reversed the anticoagulant effect of another completely and rapidly.
Conference Coverage
Antithrombotics no deterrent for emergent lap appendectomy
HOUSTON – Emergent laparoscopic appendectomy posed no significant risk for patients on irreversible antithrombotic therapy.
Conference Coverage
Pulmonary embolism common in patients hospitalized for syncope
Pulmonary embolism was identified in approximately 17% of adults hospitalized for a first episode of syncope, according to a recent study.